Urocortin (UCN) II, a newly isolated corticotropinreleasing-
factor (CRF) related peptide, has been
found to have potent cardiovascular protective effects.
To investigate the mechanisms of its vascular
protective effects, we exposed mesenteric arterial
smooth muscle cells (MASMC) from spontaneously
hypertensive rats (SHR) to UCN II to observe the
change in cell apoptosis using TUNEL assay and
measured intracellular calcium concentration ([Ca2+]i)
using confocal laser scanning microscope. In addition,
effects of UCN II on L-type calcium currents (ICa,L) were
also measured using whole-cell patch clamp. Our
results showed that UCN II concentration-dependently,
but time-independently inhibited cell apoptosis.
Astressin 2B, a special CRF 2 receptor antagonist,
had no influence on this inhibition. Hypoxia or Bay
K8644, the L-type calcium channel activator, induced
the apoptosis of MASMC from SHR. Pretreatment of
the cells with UCN II diminished the effects of hypoxia
or Bay K8644. UCN II was also observed to reduce
[Ca2+]i increase induced by KCl or Bay K8644. UCN II
concentration-dependently inhibited ICa,L, which was
not affected by astressin 2B. It did not affect the
activation of ICa,L, but markedly shifted the inactivation
curve to the left. In conclusion, UCN II inhibits the
apoptosis of MASMC from SHR via inhibiting L-type
calcium channels.